-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LY8m+9ChN4uZQYITtEqxYb1T1pTCG/2Z67GEY14/ddQk1E0MFobqwBQnDmGR8v6D orRLNDcfbczJ5rUXwl+UNw== 0001013708-97-000018.txt : 19970401 0001013708-97-000018.hdr.sgml : 19970401 ACCESSION NUMBER: 0001013708-97-000018 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19970331 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC CENTRAL INDEX KEY: 0000753772 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870412648 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 002-93277-D FILM NUMBER: 97568872 BUSINESS ADDRESS: STREET 1: 123 E 54TH ST #2H CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2124210303 FORMER COMPANY: FORMER CONFORMED NAME: MADISON FUNDING INC DATE OF NAME CHANGE: 19860413 NT 10-K 1 NOTIFICATION OF LATE FILING U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR For Period Ended: December 3 , 1996 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: ______________________________________ ________________________________________________________________________________ If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Part II, Item 6: Selected Financial Data, Item 7: Management Discussion and Analysis of Financial Condition and Results of Operations, and Item 8: Financial Statements. ________________________________________________________________________________ Part I - Registrant Information ________________________________________________________________________________ Full Name of Registrant: Medizone International, Inc. Former Name if Applicable: (originally, Madison Funding, Inc.) 123 East 54th Street _______________________________________________________________________ New York, New York 10022 _______________________________________________________________________ ________________________________________________________________________________ Part II - Rules 12b-25(b) and (c) ________________________________________________________________________________ If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b) the following should be completed. (Check box if appropriate). [X] (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; [X] (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and [X] (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. ________________________________________________________________________________ Part III - Narrative ________________________________________________________________________________ The registrant was without the financial resources to retain its accountants to complete the year end audit in 1996 in a timely manner so as to include its financial information in the report. ________________________________________________________________________________ Part IV - Other Information ________________________________________________________________________________ (1) Name and telephone number of person to contact in regard to this notification Andrew E. Goldstein, Esq. (212) 826-2000 ________________________________________________________________________________ (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). [X] Yes [ ] No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [ ] Yes [X] No If so; attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Medizone International, Inc. ________________________________________________________________________________ (Name of Registrant as specific in charter) has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized. Date March 29, 1997 By /s/Joseph S. Latino ----------------------------------------- Joseph S. Latino 2 -----END PRIVACY-ENHANCED MESSAGE-----